KAMADA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,938 ILa | -2.42% |
|
+1.52% | -12.98% |
| Mar. 06 | Transcript : Kamada Ltd., Q4 2023 Earnings Call, Mar 06, 2024 | |
| Mar. 06 | Kamada Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to Kamada Limited's Fourth ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.98% | 292M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- KMDA Stock
- News Kamada Ltd.
- Transcript : Kamada Ltd., Q4 2023 Earnings Call, Mar 06, 2024
